Keybank National Association OH Has $94.53 Million Stock Position in Danaher Co. (NYSE:DHR)

Keybank National Association OH lessened its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 411,784 shares of the conglomerate's stock after selling 11,619 shares during the period. Keybank National Association OH owned approximately 0.06% of Danaher worth $94,525,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC raised its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company's stock.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. The Goldman Sachs Group set a $250.00 price target on shares of Danaher in a research report on Wednesday, January 15th. Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target for the company. Wells Fargo & Company dropped their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. Robert W. Baird lowered their price target on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Finally, Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price target for the company in a report on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $278.00.

Danaher Trading Up 0.1 %

DHR traded up $0.23 during trading on Tuesday, reaching $205.92. 5,652,379 shares of the stock traded hands, compared to its average volume of 4,574,931. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $147.17 billion, a PE ratio of 39.00, a P/E/G ratio of 2.66 and a beta of 0.82. The stock's 50-day moving average is $223.61 and its 200 day moving average is $243.86. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 EPS. Equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio is currently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.